Brazil Diagnostic Labs Market By Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs), By Test Type (Pathology, Radiology), By End User (Walk-ins, Referrals, Corporate Clients), By Region, Competition, Forecast & Opportunities, 2018-2028F

According to the global cancer observatory, in 2020, around 592,212 new cancer cases were reported in Brazil, out of which 300,114 new cancer cases were reported in males while the number of new cancer cases reported in females were around 292,098. Prostate Cancer, Breast Cancer, Colorectum Cancer, Lung Cancer, and Thyroid Cancer were the fiver most prevalent types of cancer in Brazil.

Diagnostic tests form the fundamental component for the concept of health services. They are the inseparable essential step towards guiding patient care.

Mandated Access Helps the Brazilian Healthcare Industry

Growing Number of Independent Labs and Clinical Chains

Presence of significant number of independent labs and clinical chains has strengthened the health services availability in distinct regions of Brazil and thereby driving the diagnostic labs market growth. Public health laboratories are organized in the National System of Public Health Laboratories (SISLAB), a set of national laboratory networks for activities covering health, epidemiological and environmental surveillance, and medical care. Each network is under the responsibility of a government agency.

According to the National Registry of Health Facilities in the Ministry of Health (CNES/MS), by the end of June 2020, there were around 24,760 Therapeutic Diagnosis Support Services (SADTs) in Brazil.

Frequency of Tests and Assessments for Monitoring Individuals with Diabetes

According to report published by the Brazilian Society of Diabetes (Sociedade Brasileira de Diabetes - SBD), in 2021 the incidence of diabetes in Brazil was 7.6% of the population (approximately 16 million people).

Recent Developments

According to a report published, in 2019, DASA Labs, the biggest diagnostic company in Brazil, made a step towards integrating health care by investing in the acquisition of hospitals. After Rede D’Or acquisition, it became the second largest hospital group in the country. Similarly, Fleury, recently merged with Hermes Pardini, another leader in the Brazil diagnostics. Meanwhile Fleury along with the integrated healthcare, it has also acquired medical clinics. All these strategies followed by key players operating in the industry such as mergers & acquisitions, collaborations & partnerships, investments, and expansions not only help them in staying competitive and have an edge over other players operating in the market but also support the growth of Brazil diagnostic labs market.

Rising Geriatric Population

The increasing disease prevalence among the aged population makes them more dependent on the diagnostic labs every now and then and thereby boost the market growth.

Market Segmentation

Brazil Diagnostic Labs Market is segmented into Provider Type, test type, end users, and region. Based on product type, the market can be segmented into Hospital Based Diagnostic Labs, Diagnostic Chains and Stand-Alone Diagnostic Labs.

Market Players

DASA labs, Quest Diagnostics Incorporated, SYNLAB-Solutions in Diagnostics, Grupo Fleury, Hospital Israelita Albert Einstein, Alliar, Boris Berenstein Diagnostic Center, Clinica da Imagem do Tocantis, Abramed and Hermes Pardini, etc. are some of the leading players operating in the Brazil Diagnostic Labs Market.